Prognostic value of skin manifestations of infective endocarditis

JAMA Dermatology

Volumn 150, Issue 5, 2014, Pages 494-500

  Servy, Amandine ^a   Valeyrie Allanore, Laurence ^a   Alla, François ^b   Lechiche, Catherine ^c   Nazeyrollas, Pierre ^d   Chidiac, Christian ^e   Hoen, Bruno ^f   Chosidow, Olivier ^a,g   Duval, Xavier ^h  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

^d REIMS UNIVERSITY HOSPITAL   (France)

^e CROIX ROUSSE HOSPITAL   (France)

^f UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^g UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^h INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; BRAIN EMBOLISM; CONJUNCTIVAL HEMORRHAGE; DISEASE ASSOCIATION; FEMALE; FRANCE; HUMAN; JANEWAY LESION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POLYCYTHEMIA VERA; POPULATION RESEARCH; POST HOC ANALYSIS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PURPURA; RISK FACTOR; SKIN EXAMINATION; SKIN MANIFESTATION; STAPHYLOCOCCUS AUREUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMORBIDITY; CONJUNCTIVAL DISEASES; ENDOCARDITIS; ENDOCARDITIS, BACTERIAL; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; PURPURA; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SKIN DISEASES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 84901032945     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.8727     Document Type: Article

References (32)

1. Hoen B, Duval X. Clinical practice: infective endocarditis. N Engl J Med. 2013;368(15):1425-1433.
2. Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363(9403):139- 149.
3. Que YA, Moreillon P. Infective endocarditis. Nat Rev Cardiol. 2011;8(6):322-336.
4. Miro JM, Anguera I, Cabell CH, et al; International Collaboration on Endocarditis Merged Database Study Group. Staphylococcus aureus native valve infective endocarditis. Clin Infect Dis. 2005;41(4):507-514.
5. Hoen B, Alla F, Selton-Suty C, et al; Association Pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis. JAMA. 2002;288(1):75-81.
6. Farrior JB, Silverman ME. A consideration of the differences between a Janeway's lesion and an Osler's node in infectious endocarditis. Chest. 1976;70(2):239-243.
7. Murdoch DR, Corey GR, Hoen B, et al; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. Arch Intern Med. 2009;169(5):463-473.
8. Espinosa Parra FJ, Ramos Rincón JM, Herrero Huerta F, Pretel Serrano L, Lorenzo AA. Diagnostic utility of Osler's nodules in infectious endocarditis among parenteral drug users [in Spanish]. An Med Interna. 2002;19(6):299-301.
9. Alpert JS, Krous HF, Dalen JE, O'Rourke RA, Bloor CM. Pathogenesis of Osler's nodes. Ann Intern Med. 1976;85(4):471-473.
10. Lin CS, Lee RL, Kuo CM, Lee LC. Positive culture of the Janeway lesion in acute bacterial endocarditis. Taiwan Yi Xue Hui Za Zhi. 1980;79(1):99-102.
11. Vinson RP, Chung A, Elston DM, Keller RA. Septic microemboli in a Janeway lesion of bacterial endocarditis. J AmAcad Dermatol. 1996;35(6):984-985.
12. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345(18):1318-1330.
13. Matsui Y, Okada N, Nishizawa M, et al. An Osler's node and a Janeway lesion. Intern Med. 2009;48(16):1487-1488.
14. Kerr A Jr, Tan JS. Biopsies of the Janeway lesion of infective endocarditis. J Cutan Pathol. 1979;6(2):124-129.
15. Cardullo AC, Silvers DN, Grossman ME. Janeway lesions and Osler's nodes. J AmAcad Dermatol. 1990;22(6, pt 1):1088-1090.
16. Lévesque H, Marie I. Infection and vascular purpura [in French]. J Mal Vasc. 1999;24(3):177-182.
17. Selton-Suty C, Célard M, Le Moing V, et al; AEPEI Study Group. Preeminence of Staphylococcus aureus in infective endocarditis. Clin Infect Dis. 2012;54(9):1230-1239.
18. Duval X, Delahaye F, Alla F, et al; AEPEI Study Group. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications. J AmColl Cardiol. 2012;59(22):1968-1976.
19. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-638.
20. Habib G, Hoen B, Tornos P, et al; ESC Committee for Practice Guidelines; Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009. Eur Heart J. 2009;30(19):2369-2413.
21. Weinstein L, Rubin RH. Infective endocarditis: 1973. Prog Cardiovasc Dis. 1973;16(3):239-274.
22. Geraci JE, Martin WJ. Antibiotic therapy of bacterial endocarditis, VI: subacute enterococcal endocarditis: clinical, pathologic and therapeutic consideration of 33 cases. Circulation. 1954;10(2):173-194.
23. Newman W, Torres JH, Guck JK. Bacterial endocarditis; an analysis of fifty-two cases. Am J Med. 1954;16(4):535-542.
24. Kaipainen WJ, Seppala K. Endocarditis lenta; a review of 118 patients treated during the ten-year period 1945 to 1954. Acta Med Scand. 1956;155(1):71-81.
25. Vogler WR, Dorney ER, Bridges HA. Bacterial endocarditis. Am J Med. 1962;32:910-921.
26. Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J AmColl Cardiol. 2001;37(4):1069-1076.
27. Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis. Circulation. 2005;112(1):69-75.
28. Dickerman SA, Abrutyn E, Barsic B, et al; ICE Investigators. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis. Am Heart J. 2007;154(6):1086-1094.
29. Duval X, Iung B, Klein I, et al. IMAGE (Resonance Magnetic Imaging at the Acute Phase of Endocarditis) Study Group. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis. Ann Intern Med. 2010;152(8):497-504, W175.
30. Arber N, Militianu A, Ben-Yehuda A, Krivoy N, Pinkhas J, Sidi Y. Native valve Staphylococcus epidermidis endocarditis. Am J Med. 1991;90(6):758-762.
31. Martínez-Marcos FJ, Lomas-Cabezas JM, Hidalgo-Tenorio C, et al; Grupo Para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas. Enterococcal endocarditis. Enferm Infecc Microbiol Clin. 2009;27(10):571-579.
32. Thadepalli H, Francis CK. Diagnostic clues in metastatic lesions of endocarditis in addicts. West J Med. 1978;128(1):1-5.